What to look for in Gilead earnings
February 02, 2015 at 17:19 PM EST
Sales of Gilead Sciences Inc.’s hepatitis C drugs will be on everyone’s mind when the company reports fourth-quarter earnings late Tuesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.